Placenta praevia і Placenta accreta: сучасні методи діагностики і розродження
DOI:
https://doi.org/10.15574/HW.2019.139.8Ключові слова:
передлежання плаценти, аномально інвазивна плацента, прирощення плаценти, placenta accretа, placenta praevia, placenta increta-percretaАнотація
У статті представлені дані останніх рандомізованих досліджень і опублікованих у 2018 році двох керівництв Королівського коледжу акушерів-гінекологів Великої Британії щодо епідеміології, факторів ризику, сучасних методів діагностики, алгоритмів розродження й інноваційних хірургічних методів допомоги у разі передлежання і прирощення плаценти (pl. praevia/accreta). З точки зору доказової медицини висвітлено актуальність проблеми стосовно антенатальної діагностики патології плацентації для прогнозування і профілактики життєво небезпечних геморагічних ускладнень. Наведено дані, що свідчать про необхідність мультидисциплінарного підходу до розродження вагітних у разі встановлення діагнозу placenta percreta з проведенням донного кесарева розтину і гістеректомії без спроби відділення плаценти.
Надані останні дані будуть корисні для практикуючих акушерів-гінекологів з метою оптимального ведення і розродження вагітних з цією тяжкою акушерською патологією.
Посилання
Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Michael A. 2018. Belfort for the FIGO. Placenta Accreta Diagnosis and Management: Expert Consensus Panel. Int J Obstet Gynecol. 140; 3:281-290. https://doi.org/10.1002/ijgo.12409
ERM Jauniaux, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline 27a); RCOG: 27/09/2018. https://www.rcog.org.uk/en/guidelines-researchservices/guidelines/gtg27a/.
Irving FC, Hertig AT. 1937. A study of placenta accreta. Surg Gynec Obstet. 64: 178– 200.
Clausen, C, Lonn, L, Langhoff-Roos J. 2014. Management of placenta percreta: A review of published cases. Acta Obstet Gynecol Scand. 93: 138– 143. https://doi.org/10.1111/aogs.12295
Amsalem, H, Kingdom, JC, Farine, D et al. 2011. Planned caesarean hysterectomy versus “conserving” caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 33: 1005– 1010. https://doi.org/10.1016/S1701-2163(16)35049-6
Jauniaux E, Collins, SL, Jurkovic, D, Burton, GJ. 2016. Accreta placentation: A systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 215: 712– 721. https://doi.org/10.1016/j.ajog.2016.07.044
Jauniaux E, Bidhe A. 2017. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after caesarean delivery: A systematic review and meta-analysis. Am J Obstet Gynecol. 217: 27–36. https://doi.org/10.1016/j.ajog.2017.02.050
Esakoff TF, Handler SJ, Granados JM, Caughey AB. 2012. PAMUS: Placenta accreta management across the United States. J Matern Fetal Neonatal Med. 25: 761– 765. https://doi.org/10.3109/14767058.2011.598585
Jolley JA, Nageotte MP, Wing DA, Shrivastava, V. 2012. Management of placenta accreta: A survey of Maternal-Fetal Medicine practitioners. J Matern Fetal Neonatal Med. 25: 756– 760. https://doi.org/10.3109/14767058.2011.594467
Wright JD, Silver RM, Bonanno C et al. 2013. Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta. J Matern Fetal Neonatal Med. 26: 1602– 1609. https://doi.org/10.3109/14767058.2013.793662
Walker MG, Allen L, Windrim RC et al. 2013. Multidisciplinary management of invasive placenta previa. J Obstet Gynaecol Can. 35: 417– 425. https://doi.org/10.1016/S1701-2163(15)30932-4
Grace Tan, Jobling SE, Wallace TW, McNeilage EM, Manolitsas LJ, Hodges RJ. 2013. Surgical management of placenta accreta: A 10-year experience. Acta Obstet Gynecol Scand. 92: 445– 450. https://doi.org/10.1111/aogs.12075
Shamshirsaz AA, Fox KA, Salmanian B et al. 2015. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 212: 218.e1– 218.e9. https://doi.org/10.1016/j.ajog.2014.08.019
Eller AG, Porter TF, Soisson P, Silve RM. 2009. Optimal management strategies for placenta accreta. BJOG. 116: 648– 654. https://doi.org/10.1111/j.1471-0528.2008.02037.x
Warshak CR, Ramos GA, Eskander R et al. 2010. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 115: 65– 69. https://doi.org/10.1097/AOG.0b013e3181c4f12a
Wright, JD, Pri-Paz, S, Herzog, TJ, et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol. 2011; 205: 38.e1– 38.e6. https://doi.org/10.1016/j.ajog.2011.01.040
Al-Khan A, Gupta V, Illsley NP et al. 2014. Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod Sci. 21:761. https://doi.org/10.1177/1933719113512528
Seoud MA, Nasr R, Berjawi GA et al. 2017. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. J Neonatal Perinatal Med. 10: 9– 15. https://doi.org/10.3233/NPM-1622
Eller AG, Bennett MA, Sharshiner M et al. 2011. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 117: 331– 337. https://doi.org/10.1097/AOG.0b013e3182051db2
Camuzcuoglu A, Vural M, Hilali NG et al. 2016. Surgical management of 58 patients with placenta praevia percreta. Wien Klin Wochenschr. 128: 360– 366. https://doi.org/10.1007/s00508-016-0962-4
Norris BL, Everaert W, Posma E et al. 2016. The urologist’s role in multidisciplinary management of placenta percreta. BJU Int. 117: 961– 965. https://doi.org/10.1111/bju.13332
Wright JD, Herzog TJ, Shah M et al. 2010. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol. 115: 194– 200. https://doi.org/10.1097/AOG.0b013e3181df94e8
Brookfield KF, Goodnough LT, Lyell DJ, Butwick AJ. 2014. Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation. Transfusion. 54: 1530– 1536. https://doi.org/10.1111/trf.12483
Woldu SL, Ordone MA, Devin PC, Wright JD. 2014. Urologic considerations of placenta accreta: A contemporary tertiary care institutional experience. Urol Int. 93: 74– 79. https://doi.org/10.1159/000356064
Smulian JC, Pascual AL, Hesham H et al. 2017. Invasive placental disease: The impact of a multi-disciplinary team approach to management. J Matern Fetal Neonatal Med. 30: 1423– 1427. https://doi.org/10.1080/14767058.2016.1216099
Silver RM, Fox KA, Barton JR et al. 2015. Center of excellence for placenta accreta. Am J Obstet Gynecol. 212: 561– 568. https://doi.org/10.1016/j.ajog.2014.11.018
Brennan DJ, Schulze B, Chetty N et al. 2015. Surgical management of abnormally invasive placenta: A retrospective cohort study demonstrating the benefits of a standardized operative approach. Acta Obstet Gynecol Scand. 94: 1380– 1386. https://doi.org/10.1111/aogs.12768
Green L, Knigh M, Seeney F et al. 2016. The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: A population based study. Br J Haematol. 172: 616– 624. https://doi.org/10.1111/bjh.13864
Shamshirsaz AA, Fox KA, Erfani H et al. 2017. Multidisciplinary team learning in the management of the morbidly adherent placenta: Outcome improvements over time. Am J Obstet Gynecol. 216: 612.e1– 612.e5. https://doi.org/10.1016/j.ajog.2017.02.016
Bowman ZS, Manuck TA, Eller AG, Simon M, Silver RM. 2014. Risk factors for unscheduled delivery in patients with placenta accreta. Am J Obstet Gynecol. 210: 241.e1– 241.e6. https://doi.org/10.1016/j.ajog.2013.09.044
Rac MW, Wells CE, Twickler DM, Moschos E, McIntire DD, Dashe JS. 2015. Placenta accreta and vaginal bleeding according to gestational age at delivery. Obstet Gynecol. 125: 808– 813. https://doi.org/10.1097/AOG.0000000000000674
Robinson BK, Grobman WA. 2010. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 116: 835– 842. https://doi.org/10.1097/AOG.0b013e3181f3588d
Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. 2017. FER-ASAP Investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: An international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 45: 443– 453. https://doi.org/10.1515/jpm-2016-0050
Wong L, Smith S, Gilstrop M et al. 2016. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 91: 590– 593. https://doi.org/10.1002/ajh.24361
Tam Tam KB, Dozier J, Martin JN. 2012. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: A systematic review. J Matern Fetal Neonatal Med. 25: 329– 334. https://doi.org/10.3109/14767058.2011.576720
Abbas F, Talati J, Wasti S, Akra S, Ghaffar S, Qureshi R. 2000. Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. J Urol. 164: 1270– 1274. https://doi.org/10.1016/S0022-5347(05)67153-4
Matsubara S, Kuwata T, Usui R et al. 2013. Important surgical measures and techniques at cesarean hysterectomy for placenta previa accreta. Acta Obstet Gynecol Scand. 92: 372– 377. https://doi.org/10.1111/aogs.12074
Belfort MA, Shamshirsaz AA, Fox KA. 2017. A technique to positively identify the vaginal fornices during complicated postpartum hysterectomy. Am J Obstet Gynecol. 217: 222.e1– 222.e3. https://doi.org/10.1016/j.ajog.2017.05.001
Ioscovich A, Shatalin D, Butwick AJ, Ginosar Y, Orbach-Zinger S, Weiniger CF. 2016. Israeli survey of anesthesia practice related to placenta previa and accreta. Acta Anaesthesiol Scand. 60: 457– 464. https://doi.org/10.1111/aas.12656
Iwata A, Murayama Y, Itakura A, Baba K, Seki H, Takeda S. 2010. Limitations of internal iliac artery ligation for the reduction of intraoperative hemorrhage during cesarean hysterectomy in cases of placenta previa accreta. J Obstet Gynaecol Res. 36: 254– 259. https://doi.org/10.1111/j.1447-0756.2009.01157.x
Lilker, SJ, Meyer, RA, Downey, KN, Macarthur, AJ. Anesthetic considerations for placenta accreta. Int J Obstet Anesth. 2011; 20: 288– 292. https://doi.org/10.1016/j.ijoa.2011.06.001
Taylor NJ, Russell R. 2017. Anaesthesia for abnormally invasive placenta: A single-institution case series. Int J Obstet Anesth. 30: 10– 15. https://doi.org/10.1016/j.ijoa.2017.01.008
Munoz LA, Mendoza GJ, Gomez M, Reyes LE, Arevalo JJ. 2015. Anesthetic management of placenta accreta in a low-resource setting: A case series. Int J Obstet Anesth. 24: 329– 334. https://doi.org/10.1016/j.ijoa.2015.05.005
Kocaoglu N, Gunusen I, Karaman S, Ergenoglu AM, Firat V. 2012. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: A retrospective study. Ginekol Pol. 83: 99– 103.
Nguyen-Lu N, Carvalho JC, Kingdom J, Windrim R, Allen L, Balki M. 2016. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: A retrospective cohort study of 50 consecutive cases. Can J Anaesth. 63: 1233– 1244. https://doi.org/10.1007/s12630-016-0695-x
Hong JY, Jee YS, Yoon HJ, Kim SM. 2003. Comparison of general and epidural anesthesia in elective cesarean section for placenta previa totalis: Maternal hemodynamics, blood loss and neonatal outcome. Int J Obstet Anesth. 12: 12– 16. https://doi.org/10.1016/S0959-289X(02)00183-8
Butwick AJ, Carvalho B, El-Sayed YY. 2014. Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery. Br J Anaesth. 113: 661– 668. https://doi.org/10.1093/bja/aeu150
Walker MG, Pollard L, Talati C et al. 2016. Obstetric and anaesthesia checklists for the management of morbidly adherent placenta. J Obstet Gynaecol Can. 38: 1015– 1023. https://doi.org/10.1016/j.jogc.2016.08.015
WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet. 389: 2105– 2116. 2017.
Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V. 2016. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: A systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 95: 28– 37. https://doi.org/10.1111/aogs.12798
Lakshmi SD, Abraham R. 2016. Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: A randomized controlled study. J Clin Diagn Res. 10: 17– 21. https://doi.org/10.7860/JCDR/2016/21702.9050
Ray I, Bhattacharya R, Chakraborty S, Bagchi C, Mukhopadhyay S. 2017. Role of Intravenous tranexamic acid on caesarean blood loss: A Prospective randomised study. J Obstet Gynaecol India. 66: 347– 352. https://doi.org/10.1007/s13224-016-0915-x
Maged AM, Helal OM, Elsherbin MM et al. 2015. A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery. Int J Gynecol Obstet. 131: 265– 268. https://doi.org/10.1016/j.ijgo.2015.05.027
Chou MM, Kung HF, Hwang JI, Chen WC, Tseng JJ. 2015. Temporary prophylactic intravascular balloon occlusion of the common iliac arteries before cesarean hysterectomy for controlling operative blood loss in abnormal placentation. Taiwan J Obstet Gynecol. 54: 493– 498. https://doi.org/10.1016/j.tjog.2014.03.013
Luo F, Xie L, Xie P, Liu S, Zhu Y. 2017. Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: A retrospective study. Taiwan J Obstet Gynecol. 56: 147– 152. https://doi.org/10.1016/j.tjog.2016.11.004
Takahashi H, Ohkuchi A, Usui R, Suzuki H, Baba Y, Matsubara S. 2016. Factors contributing to massive blood loss on peripartum hysterectomy for abnormally invasive placenta: Who bleeds more? Obstet Gynecol Int. 2016: 5349063. https://doi.org/10.1155/2016/5349063
Teixidor Vinas M, Chandraharan E, Moneta MV, Belli AM. 2014. The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta. Clin Radiol. 69: e345– e351. https://doi.org/10.1016/j.crad.2014.04.005
Ballas J, Hull AD, Saenz C et al. 2012. Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: A management paradox. Am J Obstet Gynecol. 207: 216.e1– 216.e5. https://doi.org/10.1016/j.ajog.2012.06.007
Cali G, Forlani F, Giambanco L et al. 2014. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol. 179: 36– 41. https://doi.org/10.1016/j.ejogrb.2014.05.007
Carnevale FC, Kondo MM, Oliveira Sousa W et al. 2011. Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta. Cardiovasc Intervent Radiol. 34: 758– 764. https://doi.org/10.1007/s00270-011-0166-2
D’Souza DL, Kingdom JC, Amsalem H, Beecroft JR, Windrim RC, Kachura JR. 2015. Conservative management of invasive placenta using combined prophylactic internal iliac artery balloon occlusion and immediate postoperative uterine artery embolization. Can Assoc Radiol. 66: 179– 184. https://doi.org/10.1016/j.carj.2014.08.002
Duan XH, Wang YL, Han XW et al. 2015. Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. Clin Radiol. 70: 932– 937. https://doi.org/10.1016/j.crad.2015.03.008
Kidney DD, Nguye AM, Ahdoot D, Bickmore D, Deutsch LS, Majors C. 2001. Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation. Am J Roentgenol. 176: 1521– 1524. https://doi.org/10.2214/ajr.176.6.1761521
Dubois J, Garel L, Grignon A, Lema M, Leduc L. 1997. Placenta percreta: Balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol. 176: 723– 726. https://doi.org/10.1016/S0002-9378(97)70582-9
Minas V, Gul N, Shaw E, Mwenenchanya S. 2015. Prophylactic balloon occlusion of the common iliac arteries for the management of suspected placenta accreta/percreta: Conclusions from a short case series. Arch Gynecol Obstet. 291: 461– 465. https://doi.org/10.1007/s00404-014-3436-9
Mok M, Heidemann B, Dundas K, Gillespie I, Clark V. 2008. Interventional radiology in women with suspected placenta accreta undergoing caesarean section. Int J Obstet Anesth. 17: 255– 261. https://doi.org/10.1016/j.ijoa.2007.11.010
Panici PB, Anceschi M, Borgia ML et al. 2012. Intraoperative aorta balloon occlusion: Fertility preservation in patients with placenta previa accreta/increta. J Matern Fetal Neonatal Med. 25: 2512– 2516. https://doi.org/10.3109/14767058.2012.712566
Shih JC, Liu KL, Shyu MK. 2005. Temporary balloon occlusion of the common iliac artery: New approach to bleeding control during cesarean hysterectomy for placenta percreta. Am J Obstet Gynecol. 193: 1756– 1758. https://doi.org/10.1016/j.ajog.2005.08.033
Sivan E, Spira M, Achiron R et al. 2010. Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: Can it prevent cesarean hysterectomy? Am J Perinatol. 27: 455– 461. https://doi.org/10.1055/s-0030-1247599
Tan CH, Tay KH, Sheah K et al. 2007. erioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. Am J Roentgenol. 189: 1158– 1163. https://doi.org/10.2214/AJR.07.2417
Salim R, Chulski A, Romano S, Garmi G, Rudin M, Shalev E. 2015. Precesarean prophylactic balloon catheters for suspected placenta accreta: A randomized controlled trial. Obstet Gynecol. 126: 1022– 1028. https://doi.org/10.1097/AOG.0000000000001113
Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W. 2006. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol. 29: 354– 361. https://doi.org/10.1007/s00270-005-0023-2
Shrivastava V, Nageotte M, Majo C, Haydo M, Wing D. 2007. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol. 197: 402.e1– 402.e5. https://doi.org/10.1016/j.ajog.2007.08.001
Levine AB, Kuhlman K, Bonn J. 1999. Placenta accreta: Comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med. 8: 173– 176. https://doi.org/10.1002/(SICI)1520-6661(199907/08)8:4<173::AID-MFM7>3.3.CO;2-M
Clausen C, Stensballe J, Albrechtse CK, Hanse MA, Lonn L, Langhoff-Roos J. 2013. Balloon occlusion of the internal iliac arteries in the multidisciplinary management of placenta percreta. Acta Obstet Gynecol Scan. 92: 386– 391. https://doi.org/10.1111/j.1600-0412.2012.01451.x
Sentilhes L, Goffinet F, Kayem G. 2013. Management of placenta accreta. Acta Obstet Gynecol Scand. 92: 1125– 1134. https://doi.org/10.1111/aogs.12222
Greenberg JI, Suliman A, Iranpou P, Angle N. 2007. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: A cautionary case. Am J Obstet Gynecol. 197: 470.e1– 470.e4. https://doi.org/10.1016/j.ajog.2007.05.017
Sewell MF, Rosenblum D, Ehrenberg H. 2006. Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol. 108: 746– 748. https://doi.org/10.1097/01.AOG.0000201992.80130.2c
Teare J, Evans E, Belli A, Wendler R. 2014. Sciatic nerve ischaemia after iliac artery occlusion balloon catheter placement for placenta percreta. Int J Obstet Anesth. 23: 178– 181. https://doi.org/10.1016/j.ijoa.2013.11.002
Chouliaras S, Hickling DJ, Tuck JS. 2009. Thromboembolism of the leg following prophylactic balloon occlusion of the uterine arteries. BJOG. 116: 1278– 1279. https://doi.org/10.1111/j.1471-0528.2009.02217.x
Gagnon J, Boucher L, Kaufman I, Brown R, Moore A. 2013. Iliac artery rupture related to balloon insertion for placenta accreta causing maternal hemorrhage and neonatal compromise. Can J Anaesth. 60: 1212– 1217. https://doi.org/10.1007/s12630-013-0038-0
Bishop S, Butler K, Monaghan S, Chan K, Murphy G, Edozie L. 2011. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth. 20: 70– 73. https://doi.org/10.1016/j.ijoa.2010.09.012
Matsueda S, Hidaka N, Kondo Y, Fujiwara A, Fukushima K, Kato K. 2015. External iliac artery thrombosis after common iliac artery balloon occlusion during cesarean hysterectomy for placenta accreta in cervico-isthmic pregnancy. J Obstet Gynaecol Res. 41: 1826– 1830. https://doi.org/10.1111/jog.12777
Dilauro MD, Dason S, Athreya S. 2012. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: Literature review and analysis. Clin Radiol. 67: 515– 520. https://doi.org/10.1016/j.crad.2011.10.031
Neb H, Zacharowski K, Meybohm P. 2017. Strategies to reduce blood product utilization in obstetric practice. Curr Opin Anaesthesiol. 30: 294– 299. https://doi.org/10.1097/ACO.0000000000000463
McDonnell NJ, Kennedy D, Long LJ, Gallagher-Swann MC, Paech MJ. 2010. The development and implementation of an obstetric cell salvage service. Anaesth Intensive Care. 38: 492– 499. https://doi.org/10.1177/0310057X1003800313
Elagamy A, Abdelaziz A, Ellaithy M. 2013. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. Int J Obstet Anesth. 22: 289– 293. https://doi.org/10.1016/j.ijoa.2013.05.007
Lew E, Tagore S. 2015. Implementation of an obstetric cell salvage service in a tertiary women’s hospital. Singapore Med J. 56: 445– 449. https://doi.org/10.11622/smedj.2015121
Albright CM, Rouse DJ, Werner EF. 2014. Cost savings of red cell salvage during cesarean delivery. Obstet Gynecol. 124: 690– 696. https://doi.org/10.1097/AOG.0000000000000465
Esper SA, Waters JH. 2011. Intra-operative cell salvage: A fresh look at the indications and contraindications. Blood Transfus. 9: 139– 147.
Weiniger CF, Kabiri D, Ginosar Y, Ezra Y, Shachar B, Lyell DJ. 2016. Suspected placenta accreta and cesarean hysterectomy: Observational cohort utilizing an intraoperative decision strategy. Eur J Obstet Gynecol Reprod Biol. 198: 56– 61. https://doi.org/10.1016/j.ejogrb.2015.12.020
Belfort MA, Shamshiraz AA, Fox K. 2017. Minimizing blood loss at cesarean-hysterectomy for placenta previa percreta. Am J Obstet Gynecol. 216: 78.e1– 78.e2. https://doi.org/10.1016/j.ajog.2016.10.030
Rossetti D, Vitale SG, Bogani G, Rapisarda AM, Gulino FA, Frigerio L. 2015. Usefulness of vessel-sealing devices for peripartum hysterectomy: A retrospective cohort study. Updates Surg. 67: 301– 304. https://doi.org/10.1007/s13304-015-0289-0
Arendas K, Lortie KJ, Singh SS. 2012. Delayed laparoscopic management of placenta increta. J Obstet Gynaecol Can. 34: 186– 189. https://doi.org/10.1016/S1701-2163(16)35162-3
Smith DD, Perez-Delboy A, Burke WM, Tergas AI. 2016. Buttock necrosis after uterine artery embolization for delayed hysterectomy in placenta percreta. Case Rep Obstet Gynecol. 2016: 6921280. https://doi.org/10.1155/2016/6921280
Rupley DM, Tergas AI, Palmerola KL, Burke WM. 2016. Robotically assisted delayed total laparoscopic hysterectomy for placenta percreta. Gynecol Oncol Rep. 17: 53– 55. https://doi.org/10.1016/j.gore.2016.05.009
Skinner BD, Golichowski AM, Raff GJ. 2012. Laparoscopic-assisted vaginal hysterectomy in a patient with placenta percreta. JSLS. 16: 143– 147. https://doi.org/10.4293/108680812X13291597717022
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2019 Здоров’я жінки
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
